Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


An apple a day to keep inflammation away?


An apple a day to keep inflammation away?

Auckland, New Zealand. 10 December 2012…New research suggests that apples may be good for the millions of people worldwide suffering from inflammatory diseases.

Scientists at Plant & Food Research analysed the concentrations of 27 compounds thought to be beneficial to health in 109 different cultivars of apple - 94 from the Plant & Food Research germplasm collection and 15 grown in Luxembourg. From these, five cultivars were selected that represented the extremes of chemical profiles identified. Extracts of the flesh and skin from each of these cultivars were analysed in laboratory cell-based assays for the apples’ effect on key components of human inflammation.

The results showed that the apples with high levels of two families of compounds -the procyanidins and triterpenes - inhibited the activation of two molecules (NF-B and TNF) known to play a role in inflammation and are key in inflammatory diseases, such as Inflammatory Bowel Disease (IBD).

“Apple is one of the most highly consumed fruits worldwide,” says Dr William Laing, Science Group Leader Biological Chemistry and Bioactives at Plant & Food Research. “Understanding which compounds in apple influence pathways in disease, such as IBD, allows us to breed new varieties of apple with more of these compounds that can then be used as ingredients in foods specifically designed to control the disease symptoms.”

Scientists from Plant & Food Research worked in conjunction with a research team at the Centre de Recherche Public-Gabriel Lippmann in Luxembourg. The research was conducted as part of the Nutrigenomics New Zealand programme, a multidisciplinary research collaboration between Plant & Food Research, The University of Auckland and AgResearch, and funded by the Ministry of Business, Innovation and Employment. The programme aims to determine how food and food composition affects health based on genetic information. Ultimately, the programme intends to develop gene-specific foods that prevent, control or cure disease. The initial target for the programme is Crohn’s disease and other inflammatory bowel disorders. Approximately 15,000 people are affected by these disorders in New Zealand.

The research is published in the latest edition of the Journal of Agricultural and Food Chemistry.


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Ruataniwha: Greenpeace Launches Legal Challenge Against $1b Dam Plan

Greenpeace NZ is launching a legal challenge against a controversial plan to build a dam that’s set to cost close to $1 billion and will pollute a region’s rivers. More>>

ALSO:

Inequality: Top 10% Of Housholds Have Half Of Total Net Worth

The average New Zealand household was worth $289,000 in the year to June 2015, Statistics New Zealand said today. However wealth was not evenly distributed, with the top 10 percent accounting for around half of total wealth. In contrast, the bottom 40 percent held 3 percent of total wealth. More>>

ALSO:

What Winter? Temperature Records Set For June 20-22

The days around the winter soltice produced a number of notably warm tempertaures. More>>

Conservation Deal: New Kākāpō Recovery Partnership Welcomed

Conservation Minister Maggie Barry says the new kakapo recovery partnership between DOC and Meridian Energy is great news for efforts to save one of New Zealand’s most beloved birds. More>>

ALSO:

Tech Sector Report: Joyce Warns Asian Tech Investors View NZ As Hobbits And Food

Speaking in Wellington at the launch of a report showcasing the value of the technology sector to the New Zealand economy, Joyce said more had to be done to tell the country's technology stories overseas. More>>

ALSO:

Mediaglommeration: APN Gets OIO Approval For Demerger Plan

APN News & Media has received Overseas Investment Office approval for its plan to split out its NZME unit ahead of a potential merger with rival Fairfax Media's New Zealand operations. More>>

New Paper: Ninety-Day Trial Period Has No Impact On Firms' Hiring

The introduction of a 90-day trial period has had no impact on hiring by New Zealand companies although they are now in widespread use, according to researchers at Motu Economic and Public Policy Research. More>>

ALSO:

Corrections: Serco Exits Equity Stake, Remains As Operator

Serco has sold its equity stake in the company that holds the contract to design, build and run Wiri Prison in South Auckland but continues as sub-contractor to operate the facility. More>>

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news